Funding for research on Alzheimer's disease

Civitan Norway's research fund supports Andersen's team to test novel approaches to target the proteins responsible for Alzheimer's disease

Researcher Stian Foss (in front) and group leader Jan Terje Andersen. Photo: Simone Mester

The Laboratory for Adaptive Immunity and Homeostasis received 200 000 NOK from Civitan Norway Research fund (Civitan Norges Forskningsfond for Alzheimers sykdom) for basic research tailoring antibodies to target the protein aggregates in the brain, responsible for Alzheimer's disease. 

Link to announcement (in Norwegian) 

 

Published June 19, 2024 4:42 PM - Last modified June 19, 2024 4:56 PM
E-mail this page